Apellis Pharmaceuticals, Inc. · NASDAQ:APLS
Dunlop A. Sinclair reported 5 trades in Apellis Pharmaceuticals, Inc. shares (Form 4)
Traded May 14, 2026 · Filed May 14, 2026
On May 14, 2026, Dunlop A. Sinclair (Director) reported 5 trades in Apellis Pharmaceuticals, Inc. shares, leaving 0 shares. Filed May 14, 2026 (Form 4).
- Shares
- 161,567 shares
- Holding after
- 0 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 14, 2026 | Common Stock | Other | 161,567 | 0 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 3,062 | 0 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 5,744 | 0 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 7,961 | 0 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 3,544 | 0 | Direct |
Source
Related
- Apellis Pharmaceuticals, Inc.
- Dunlop A. Sinclair
- Apellis Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Morgan Stanley · Jun 5, 2026
- Schedule 13G/A · Deep Track Capital, LP · May 15, 2026
- Schedule 13G/A · Rtw Investments, LP · May 15, 2026
- Form 4 · Chopas James George · May 14, 2026
- Form 4 · Dolsten Mikael · May 14, 2026